-
What's Behind TrovaGene's Volatile Ride?
Friday, March 8, 2019 - 12:28pm | 684It's déjà vu for biotech investors, who witnessed a wild rally in Bio-Path Holdings Inc (NASDAQ: BPTH) this week. Shares of another thinly traded, nano-cap biotech are clocking double-digit gains for the second consecutive session. TrovaGene Inc (NASDAQ: TROV),...
-
Noble Financial Upgrades Veeco Instruments, Cites 'Swelling' Backlog
Wednesday, February 18, 2015 - 11:54am | 194In a report published Wednesday, Noble Financial Capital Markets analyst Mark Miller upgraded shares of Veeco Instruments Inc. (NASDAQ: VECO) to Buy from Hold with a $42 price target following the company's fourth-quarter results on Tuesday. Veeco earned $0.13 during its fourth quarter, better than...
-
UPDATE: Noble Financial Downgrades CACI International
Monday, December 15, 2014 - 12:15pm | 236Noble Financial downgraded CACI International Inc (NYSE: CACI) from Buy to Hold. Analyst Mark Jordan noted, “While fundamentals are moving in a positive direction, we are lowering our rating...due to the stock's recent price increase to within 3 percent of our prior price target of $...
-
Noble Financial Upgrades Gastar Exploration To Buy
Thursday, December 11, 2014 - 9:10am | 49Analysts at Noble Financial upgraded Gastar Exploration (NYSE: GST) from Hold to Buy. Gastar Exploration shares have dropped 50.48% over the past 52 weeks, while the S&P 500 index has gained 14.12% in the same period. Gastar Exploration's shares fell 1.55% to $2.54 in pre-market trading.
-
UPDATE: Noble Financial Upgrades Gastar Exploration As Value Should Rise
Thursday, December 11, 2014 - 8:29am | 179In a report published Thursday, Noble Financial analyst Philip Dodge upgraded the rating on Gastar Exploration Inc (NYSE: GST) from Hold to Buy, and reiterated the $6.00 price target. In the report, Noble Financial noted, “Taking the full brunt of the bear market in E&P stocks, Gastar now sells...
-
Seagate Technology Analyst Roundup
Monday, October 27, 2014 - 2:38pm | 274Seagate Technology PLC (NASDAQ: STX) beat Q1 FY 2015 earnings expectations Monday. The company reported revenue of $3.79 billion and EPS of $1.34, above estimates of $3.63 billion and $1.24. Below are some highlights from analysts after the earnings announcement along with current ratings and...
-
Analysts See Trouble In NetScout Systems/Danaher Deal
Tuesday, October 14, 2014 - 2:25pm | 259NetScout Systems, Inc. (NASDAQ: NTCT) plunged 14 percent Tuesday in the wake of its plan to acquire a competitor's communications business for $2.6 billion. Danaher Corporation (NYSE: DHR) shareholders will receive 62.5 million NetScout shares in exchange for the Danaher unit. NetScout,...
-
Noble Financial Initiates Coverage On Primo Water
Wednesday, September 3, 2014 - 7:50am | 72In a note released Tuesday, Noble Financial initiated coverage on Primo Water (NASDAQ: PRMW) with a Buy rating and $6.50 price target. This mirrors coverage initiated last week by Lake Street Capital. The $6.50 price target provides nearly 38 percent upside, with Primo Water closing Tuesday...
-
UPDATE: Noble Financial Downgrades Hanger
Friday, August 8, 2014 - 9:16am | 130In a note released Friday, Noble Financial analyst Michael Petusky downgraded shares of Hanger (NYSE: HGR) from Buy to Hold. Petusky said the company reported "very disappointing" results for the second quarter, noting an adjusted EPS of $0.40 compared to the firm's $0.57 estimate...
-
Noble Financial Initiates Heron Therapeutics At Buy
Thursday, August 7, 2014 - 7:45am | 60Noble Financial initiated coverage on shares of Heron Therapeutics (NASDAQ: HRTX) with a Buy rating. The target price for Heron Therapeutics is set to $18. Heron Therapeutics shares have declined 8.26% over the past 52 weeks, while the S&P 500 index has gained 13.56% in the same period. Heron...
-
UPDATE: Noble Financial Upgrades Virtusa
Wednesday, August 6, 2014 - 11:55am | 98In a note issued Wednesday, Noble Financial upgraded shares of Virtusa (NASDAQ: VRTU) from Hold to Buy with a $39 price target. The team at Noble Financial stated, "We expect Virtusa to achieve rapid revenue/EPS growth over the nest several years as it gains market share in the under-...
-
Noble Financial Upgrades SolarWinds from Hold to Buy
Wednesday, February 8, 2012 - 9:54am -
Noble Financial Upgrades SolarWinds from Buy to Hold
Wednesday, February 8, 2012 - 9:33am -
Hearing Noble Financial Upgrades Siga Technologies from Hold to Buy
Friday, September 23, 2011 - 8:36am -
Noble Financial Downgrades RSTI To Hold
Friday, February 4, 2011 - 6:02am | 40Analysts at Noble Financial downgrade Rofin-Sinar Technologies (NASDAQ: RSTI) from “buy” to “hold.” RSTI shares fell 1.83% to close at $39.75 yesterday. More Analyst Ratings here